US 7714137
Pyridyl substituted heterocycles useful for treating or preventing HCV infection
granted A61PA61P1/16A61P31/12
Quick answer
US patent 7714137 (Pyridyl substituted heterocycles useful for treating or preventing HCV infection) held by Rigel Pharmaceuticals, Inc. expires Mon May 06 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue May 11 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 06 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 1
- CPC classes
- A61P, A61P1/16, A61P31/12